Bye-bye urinary gonadotrophins? Recombinant FSH: A real progress in ovulation induction and IVF?

Human Reproduction

Volumn 18, Issue 3, 2003, Pages 476-482

  Gleicher, Norbert ^a,b,c   Vietzke, Mary ^a   Vidali, Andrea ^b  

^a Chicago Center for Human Reproduction   (United States)

^b CENTER FOR HUMAN REPRODUCTION   (United States)

^c Foundation for Reproductive Medicine   (United States)

Author keywords

Gonadotrophins; Infertility; IVF; Ovulation induction

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT GONADOTROPIN DERIVATIVE; RECOMBINANT LUTEINIZING HORMONE; SEX HORMONE ANTAGONIST; UNCLASSIFIED DRUG; URINARY GONADOTROPIN DERIVATIVE;

AGE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOSE CALCULATION; DRUG ABSORPTION; DRUG APPROVAL; DRUG CONTAMINATION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MANUFACTURE; DRUG POTENCY; DRUG PURITY; DRUG SAFETY; DRUG SELECTIVITY; EDEMA; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; IMMUNOGENICITY; INJECTION PAIN; INTRAUTERINE INSEMINATION; META ANALYSIS; NONHUMAN; OUTCOMES RESEARCH; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVULATION INDUCTION; PUBLISHING; REVIEW; RISK ASSESSMENT; UNITED STATES;

FALLOPIA;

EID: 0037342821     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg099     Document Type: Review

References (51)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I., Amin, Y.M., Sattar, M.A. and Elattar, E. (1998) Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome. Fertil. Steril., 69, 72s-75s.
2. Agarwal, R., Holmes, J. and Jacobs, H.S. (2000) Follicle stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: A meta analysis. Fertil. Steril., 73, 338-343.
3. Albano, C., Smitz, J. and Camus, M. (1996) Pregnancy and birth in an in vitro fertilization cycle after controlled ovarian stimulation in a woman with history of allergic reaction to human menopausal gonadotrophin. Hum. Reprod., 11, 1632-1634.
4. American Society for Reproductive Medicine (1999) Guidelines for Advertising by ART Programs. A Practice Committee Report. A Committee Opinion. Birmingham, AL.
5. Balasch, J. and Barri, P.N. (2001) Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction: The clinician's perspective. J. Assist. Reprod. Genet., 18, 45-55.
6. Balen, A. (2002) Bye-bye urinary gonadotrophins?: Is there a risk of prion disease after administration of urinary-derived gonadotrophins? Hum. Reprod., 17, 1676-1680.
7. Barlow, D.H. (2001) Cost-effectiveness modelling. Hum. Reprod., 16, 2479-2480.
8. Barnes, R.B., Namnoum, A.B., Rosenfeld, R.L. and Layman, L.C. (2002) The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: Clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum. Reprod., 17, 88-91.
9. Bentick, B., Shaw, R.F., Iffland, C.A., Burford, G. and Bernard, A. (1988) A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization. Fertil. Steril., 50, 79-84.
10. Biffoni, M., Marcucci, I., Ythier, A. and Eshkol, A. (1998) Effect of urinary gonadotropin preparations on human in vitro immune function. Hum. Reprod., 13, 2430-2434.
11. Blumenfeld, Z. (2001) Recombinant FSH vs. urinary FSH: Retrospective study of matched pairs for type of treatment (IVF or ICSI). Fertil. Steril., 76, 1289-1290.
12. Chappel, S.C. and Howles, C. (1991) Re-evaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
13. Check, J.H. and Fine, W. (1997) Similar pregnancy and spontaneous abortion rates after treatment with low-dose human menopausal gonadotropin versus pure follicle stimulating hormone in women with luteal phase defects. Clin. Exp. Obstet. Gynecol., 24, 5-7.
14. Daya, S. (2002) Updated meta analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil. Steril., 77, 711-714.
15. Daya, S. and Gunby, J. (1999) Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum. Reprod., 14, 2207-2215.
16. Daya, S., Gunby, J. and Hughes, E.G. (1995) Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: A meta analysis. Fertil. Steril., 64, 347-354.
17. Daya, S., Ledger, W., Auray, J.P., Duru, G., Silverberg, K., Wikland, M., Bouzayen, R., Howles, C.M. and Beresniak, A. (2001) Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the U.K. Hum. Reprod., 16, 2563-2569.
18. De Placido, G., Mollo, A., Alviggi, C., Strina, I., Varrichio, M.T., Ranieri, A., Colacurci, N., Tolino, A. and Wilding, M. (2001) Rescue of IVF cycles by hMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum. Reprod., 9, 1875-1879.
19. Edelstein, M.C., Brzuski, R.G., Jones, G.S., Simonetti, S. and Muasher, S. (1990) Equivalency of human menopausal gonadotropin and follicle stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression. Fertil. Steril., 53, 103-106.
20. Ferring Pharmaceuticals Inc. (2002) Data on File. Tarrytown, N.Y.
21. Fevold, H. (1941) Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology, 28, 33-36.
22. Franklin, R.D., Bronson, R.A. and Kutteh, W.H. (1998) Gonadotropins do not induce antiphospholipid antibodies. Am. J. Reprod. Immunol., 40, 359-363.
23. Gleicher, N. (2002) Some thoughts on the autoimmune Reproductive Failure Syndrome (RAFS) and Th-1 versus Th-2 immune responses. Am. J. Reprod. Immunol., 48, 252-255.
24. Gleicher, N. and Karande, V. (2000) Generic human menopausal gonadotropin (hMG) in place of more costly follicle-stimulating hormone (FSH) for routine ovulation induction. J. Assist. Reprod. Genet., 17, 489-495.
25. Gleicher, N., Oleske, D., Tur-Kaspa, I., Vidali, A. and Karande, V. (2000) Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N. Engl. J. Med., 343, 2-7.
26. Goldfarb, A.F., Schlatt, S. and Mansi, M.L. (1982) A life-table analysis of pregnancy yield in fixed low-dose menotropin therapy for patients in whom clomiphene citrate failed to induce ovulation. Fertil. Steril., 37, 639-644.
27. Gordon, U.D., Harrison, R.F., Fawzy, M., Hennelly, B. and Gordon, A.C. (2001) A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil. Steril., 75, 324-331.
28. Harika, G., Gabriel, R. and Quereux, C. (1994) Hypersensitization to human menopausal gonadotropins with anaphylactic shock syndrome during a fifth in vitro fertilization cycle. J. Assist. Reprod. Genet., 11, 51-53.
29. Homburg, R., Arman, N.A. and Esher, A. (1988) Influence of serum luteinizing hormone concentration on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J., 297, 1024-1026.
30. Imthurn, B., Macas, E., Roselli, M. and Keller, P.J. (1996) Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum. Reprod., 11, 2387-2389.
31. Lavy, G., Pellicer, A., Diamond, M.P. and DeCherney, A.H. (1988) Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: A randomized prospective study. Fertil. Steril., 50, 74-78.
32. Lunenfeld, B. and Lunenfeld, E. (1997) Ovulation induction with human menopausal gonadotropins. Seibel M.M. (ed.) Infertility: A Comprehensive Text. 2nd ed. Stamford, CT: Appleton & Lange, pp. 507-523.
33. Lunenfeld, B., Sulimovici, S., Rabau, E. and Eshkol, A. (1962) L'induction de l'ovulation dans les amenorhees hypophysaires per un traitement combiné de gonadotrophines urinaires ménopausiques et de gonadotrophines chorioniques. Soc. Fr. Gynecol., 5, 346-351.
34. Ng, E.H.Y., Lau, E.Y.L., Yeung, W.S.H. and Ho, P.C. (2001) HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: A prospective randomized trial. Hum. Reprod., 16, 319-320.
35. Nichols, J., Wochenhauer, E., Fein, S.H., Nardi, R.V., Marshall, D.C. and the Repronex® SC Ovulation Induction Study Group (2001) Subcutaneously administered Repronex® in digoovulatory female patients undergoing ovulation induction is as effective and well-tolerated as intramuscular human menopausal gonadotropins treatment. Fertil. Steril., 76, 58-66.
36. Noci, I., Biagiotti, R. and Maggi, M. (1998) Low day 3 luteinizing hormone levels are predictive of reduced response to ovarian stimulation. Hum. Reprod., 13, 531-534.
37. Odink, J., Zuiderwijk, P.B.M. and Schoen, E.D. (1995) A prospective double-blind, split subject study on local skin reactions after administration of human menopausal gonadotropin preparation to healthy female volunteers. Hum. Reprod., 10, 1045-1047.
38. Prevost, R.R. (1998) Recombinant follicle-stimulating hormone: New biotechnology for infertility. Pharmacotherapy, 18, 1001-1010.
39. Redfearn, A., Hughes, E.G. and O'Connor, M. (1995) Delayed-type hypersensitivity to human gonadotropin: Case report. Fertil. Steril., 64, 855-856.
40. Regan, L., Owen, E.J. and Jacobs, H.S. (1990) Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet, 336, 1141-1144.
41. Schoor, E., Van Weissenbruch, M. and Engelbert, M. (1999) Bioactivity of luteinizing hormone during normal puberty in girls and boys. Horm. Res., 51, 230-237.
42. Scoccia, B., Blumenthal, P., Wagner, C., Prins, G., Scommengna, A. and Marut, E. (1987) Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program. Fertil. Steril., 48, 446-449.
43. Silverberg, K., Daya, S., Auray, J.P., Duru, G., Ledger, W., Wikland, M., Bouzayen, R., O'Brien, M., Falk, B. and Beresniak, A. (2002) Analysis of cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil. Steril., 77, 103-113.
44. Söderström-Anttila, V., Foudila, T. and Hovatta, O. (1996) A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotropin for ovarian hyperstimulation in an oocyte donation program. Hum. Reprod., 11, 1864-1870.
45. Stanger, J.D. and Yovich, J.L. (1985) Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during follicular phase. Br. J. Obstet. Gynecol., 92, 385-393.
46. Strehler, E., Abt, M., El-Danasouri, I., DeSanto, M. and Sterzik, K. (2001) Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil. Steril., 75, 332-336.
47. Sykes, D., Out, H.J., Palmer, S.J. and Von Loon, J. (2001) The cost-effectiveness of IVF in the U.K.: A comparison of three gonadotrophin treatments. Hum. Reprod., 16, 2557-2562.
48. Tsapoulis, A.D., Zourlas, P.A. and Comninos, A.C. (1978) Observations on 320 infertile patients treated with human gonadotropins (human menopausal gonadotropin/human chorionic gonadotropin). Fertil. Steril., 29, 492-495.
49. Westergaard, L.G., Erb, K., Laursen, S.B., Rex, S. and Rasmussen, P.E. (1996) The effect of human menopausal gonadotrophin and highly purified urine-derived follicle stimulating hormone on the outcome of in vitro fertilization in down-regulated normogonadotropic women. Hum. Reprod., 11, 1209-1213.
50. Westergaard, L.G., Erb, K., Laursen, S.B., Rex, S. and Rasmussen, P.E. (2001) Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study. Fertil. Steril., 76, 543-549.
51. Yarali, H., Bukulmez, O. and Gurgan, T. (1999) Urinary follicle stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic chronic anovulation: A prospective randomized study. Fertil. Steril., 72, 276-281.